A股異動丨中旗股份(300575.SZ)漲近7%續創新高 獲券商持續唱好
格隆匯7月29日丨中旗股份(300575.SZ)延續上漲行情,現報51.68元,漲6.71%,暫成交2.22億元,最新總市值71.34億元。近期股價呈不斷突破新高之勢,6月以來累計上漲超80%持續創下新高。中信建投指出,公司Q2單季業績已恢復至歷史最佳,後續成長不斷。此前,公司擬建設總投資額20億元的15500噸新型農藥原藥及相關產品項目,太平洋證券稱15500噸新型農藥原藥項目細節批露,利潤有望再上新台階,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.